Trial Search Results

Localized Therapeutics for the Treatment of Gastrointestinal Disorders

The purpose of this study is to determine the patient preference for a biocompatible thermosensitive solution-gel versus water or saline (liquid) enema. The thermosensitive solution-gel is comprised of poloxamer, an inactive compound that is designated as GRAS (generally recognized as safe) by FDA. It could subsequently be used as a medium for drug delivery. The poloxamer (gel) is administered to study participants in order to assess preference and proximal distribution.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Other: Thermosensitive gel rectal formulation
  • Other: Saline enema

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Generally healthy

   - Age 18 to 70 years old

   - Non-pregnant

Exclusion Criteria:

   - GI complaints

   - Pregnancy

   - Patients with previous colonic surgery or current bowel injury or obstruction

   - Allergies to contrast

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sidhartha Sinha, MD
Recruiting